We believe an information gap exists for early-stage companies in the Femtech space. Investors are struggling to understand the space more broadly and comprehensively than just the high profile exits in the news. What is Femtech vis a vis healthcare? How does it relate to or combine with other approaches to health? Is it even tech? How can I participate and/or why do I care? These are all good questions from investors that we address in this, our first report from Piggyback Health, called the “Shape of the Space”.
Here we provide a data-driven story from our unique POV for investors that want to know more. We define the Femtech landscape through innovative new metrics and highlight several areas of opportunity for follow up.
For this report, we reviewed 1000 Femtech companies that span the globe (50% headquartered in the US, and 50% exUS) and investment funding levels with an emphasis on early stage funding (up to $3M total funds raised to date). We also supplemented our findings with market research in US women distributed across age and race to help investors understand user needs.
Adding product to your cart
Use left/right arrows to navigate the slideshow or swipe left/right if using a mobile device
Choosing a selection results in a full page refresh.
Press the space key then arrow keys to make a selection.
